Measures · C16 in 2025 · Part C · HD2 Managing Chronic (Long Term) Conditions
Statin Therapy for Patients with Cardiovascular Disease
Chronic ConditionsHealth PlanMedication AdherenceSource: HEDIS
- What it measures
- This rating is based on the percent of plan members with heart disease who get the right type of cholesterol-lowering drugs. Health plans can help make sure their members are prescribed medications that are more effective for them.
- How it's calculated
- The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) (denominator) and were dispensed at least one high or moderate-intensity statin medication during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2023 – 12/31/2023
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Statin Therapy for Patients with Cardiovascular Disease (SPC)
- Exclusions
Show
Exclude members who meet any of the following criteria: • Pregnancy during the measurement year or year prior to the measurement year. • In vitro fertilization in the measurement year or year prior to the measurement year. • Dispensed at least one prescription for clomiphene (Table SPC-A) during the measurement year or the year prior to the measurement year. • ESRD or dialysis during the measurement year or the year prior to the measurement year. • Cirrhosis during the measurement year or the year prior to the measurement year. • Myalgia, myositis, myopathy, or rhabdomyolysis during the measurement year. • Members in hospice or using hospice services any time during the measurement year. • Members who died any time during the measurement year. • Members receiving palliative care any time during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year who meet either of the following: – Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. – Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file to determine if a member had an LTI flag during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year with frailty and advanced illness during the measurement year. Members must meet both of the following frailty and advanced illness criteria to be excluded: – At least two indications of frailty with different dates of service during the measurement year. – Any of the following during the measurement year or the year prior to the measurement year (count services that occur over both years): 1. At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits, virtual check-ins, nonacute inpatient encounters, or nonacute inpatient discharges on different dates of service, with an advanced illness diagnosis. Visit type need not be the same for the two visits. 2. At least one acute inpatient encounter with an advanced illness diagnosis. 3. At least one acute inpatient discharge with an advanced illness diagnosis on the discharge claim. 4. A dispensed dementia medication. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2023 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by 2023 disasters.
From the 2025 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2025 star distribution
Not rated: Not enough data available (82); Plan too small to be measured (80); Plan too new to be measured (60); Plan not required to report measure (58); No data available (40); Benefit not offered by plan (2)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 82 % | >= 82 % to < 86 % | >= 86 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2026 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 91 % | >= 91 % |
| 2025 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 92 % | >= 92 % |
| 2024 | MA | < 79 % | >= 79 % to < 84 % | >= 84 % to < 86 % | >= 86 % to < 90 % | >= 90 % |
| 2023 | MA | < 75 % | >= 75 % to < 81 % | >= 81 % to < 85 % | >= 85 % to < 89 % | >= 89 % |
| 2022 | MA | < 76 % | >= 76 % to < 81 % | >= 81 % to < 84 % | >= 84 % to < 89 % | >= 89 % |
| 2021 | MA | < 75% | >= 75% to < 79% | >= 79% to < 83% | >= 83% to < 87% | >= 87% |
| 2020 | MA | < 75% | ? 75% to < 79% | ? 79% to < 83% | ? 83% to < 87% | ? 87% |
| 2019 | MA | < 70% | ? 70% to < 76% | ? 76% to < 81% | ? 81% to < 85% | ? 85% |
Lowest-scoring contracts, 2025
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H5435 UnitedHealthcare | UnitedHealth Group, Inc. | 1,420 | 73 | 1 | 0 | 15 | 0% |
| H4754 PacificSource Medicare | PacificSource | 2,527 | 75 | 1 | −1 | 13 | 0% |
| H1799 Passport Advantage | Molina Healthcare, Inc. | 2,617 | 75 | 1 | 0 | 13 | 0% |
| H1189 CHRISTUS Health Advantage | CHRISTUS Health | 8,875 | 75 | 1 | 0 | 13 | 0% |
| R5941 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 13,077 | 75 | 1 | 0 | 13 | 0% |
| H6743 ATRIO Health Plans | ATRIO Health Plans | 21,042 | 75 | 1 | 0 | 13 | 0% |
| H4931 Banner Medicare Advantage | Banner Health | 10,894 | 75 | 1 | 0 | 13 | 0% |
| H6550 Wellcare | Centene Corporation | 2,010 | 76 | 1 | −1 | 12 | 2% |
| H3071 Clear Spring Health | Group 1001 | — | 76 | 1 | −3 | 12 | 2% |
| H7093 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 9,924 | 76 | 1 | −1 | 12 | 2% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 76 | 1 | 0 | 12 | 2% |
| H4624 Zing Health | Zing Health Consolidator, Inc | 39,459 | 78 | 1 | — | 10 | 2% |
| H5843 Banner Medicare Advantage | Banner Health | 7,427 | 78 | 1 | — | 10 | 2% |
| H4036 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 369,356 | 78 | 1 | −1 | 10 | 2% |
| H8553 Wellcare | Centene Corporation | — | 78 | 1 | — | 10 | 2% |
| H3554 Arkansas Blue Medicare | USAble Mutual Insurance Company | — | 78 | 1 | 0 | 10 | 2% |
| H5010 Asuris Northwest Health | Cambia Health Solutions, Inc. | — | 78 | 1 | — | 10 | 2% |
| H7175 Wellcare | Centene Corporation | — | 78 | 1 | 0 | 10 | 2% |
| H9147 Blue Cross and Blue Shield of North Carolina | CuraCor Solutions Corp. | 3,516 | 78 | 1 | — | 10 | 2% |
| H7323 Wellcare | Centene Corporation | 2,017 | 78 | 1 | −1 | 10 | 2% |
| H3810 AllCare Advantage | AllCare Health, Inc. | 2,485 | 78 | 1 | −1 | 10 | 2% |
| H7379 CareFirst BlueCross BlueShield Medicare Advantage | CareFirst, Inc. | 47,957 | 79 | 1 | — | 9 | 5% |
| H5590 Wellcare | Centene Corporation | 26,580 | 79 | 1 | −1 | 9 | 5% |
| H2582 UnitedHealthcare | UnitedHealth Group, Inc. | — | 79 | 1 | −1 | 9 | 5% |
| H7115 Memorial Hermann Health Plan | Memorial Hermann Health System | 14,602 | 79 | 1 | −1 | 9 | 5% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C18 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C19 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C20 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C21 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C22 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2017 – 12/31/2017 | 1 | HEDIS |